FLEBOGAMMA 5% DIF Human normal immunoglobulin 10g/200mL intravenous use injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

flebogamma 5% dif human normal immunoglobulin 10g/200ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; sorbitol; water for injections - replacement therapy in: primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia, common variable immunodeficiency, severe combined immunodeficiency, wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; and children with congenital aids and recurrent infections. immunomodulation: idiopathic thrombocytopenia purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, guillian barre syndrome. allogenic bone marrow transplantation.

FLEBOGAMMA 5% DIF Human normal immunoglobulin 5g/100mL intravenous use injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

flebogamma 5% dif human normal immunoglobulin 5g/100ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy in: primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia, common variable immunodeficiency, severe combined immunodeficiency, wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; and children with congenital aids and recurrent infections. immunomodulation: idiopathic thrombocytopenia purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, guillian barre syndrome. allogenic bone marrow transplantation.

FLEBOGAMMA 5% DIF Human normal immunoglobulin 2.5g/50mL intravenous use injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

flebogamma 5% dif human normal immunoglobulin 2.5g/50ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; sorbitol; water for injections - replacement therapy in: primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia, common variable immunodeficiency, severe combined immunodeficiency, wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; and children with congenital aids and recurrent infections. immunomodulation: idiopathic thrombocytopenia purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, guillian barre syndrome. allogenic bone marrow transplantation.

FLEBOGAMMA 5% DIF Human normal immunoglobulin 0.5g/10mL intravenous use injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

flebogamma 5% dif human normal immunoglobulin 0.5g/10ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy in: primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia, common variable immunodeficiency, severe combined immunodeficiency, wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; and children with congenital aids and recurrent infections. immunomodulation: idiopathic thrombocytopenia purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, guillian barre syndrome. allogenic bone marrow transplantation.

EVOGAM normal immunoglobulin (human) 16% w/v, 3.2g/20mL injection solution vial for subcutaneous use Australia - English - Department of Health (Therapeutic Goods Administration)

evogam normal immunoglobulin (human) 16% w/v, 3.2g/20ml injection solution vial for subcutaneous use

csl behring australia pty ltd - normal immunoglobulin, quantity: 3.2 g - injection, solution - excipient ingredients: human immunoglobulin a; glycine; water for injections - evogam is indicated in adults and children for replacement therapy in: primary immunodeficiency disease (pid) and symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use Australia - English - Department of Health (Therapeutic Goods Administration)

evogam normal immunoglobulin (human) 16% w/v, 1.6g/10ml injection solution vial for subcutaneous use

csl behring australia pty ltd - normal immunoglobulin, quantity: 1.6 g - injection, solution - excipient ingredients: water for injections; human immunoglobulin a; glycine - evogam is indicated in adults and children for replacement therapy in: primary immunodeficiency disease (pid) and symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

EVOGAM normal immunoglobulin (human) 16% w/v, 0.8g/5mL injection solution vial for subcutaneous use Australia - English - Department of Health (Therapeutic Goods Administration)

evogam normal immunoglobulin (human) 16% w/v, 0.8g/5ml injection solution vial for subcutaneous use

csl behring australia pty ltd - normal immunoglobulin, quantity: 0.8 g - injection, solution - excipient ingredients: glycine; human immunoglobulin a; water for injections - evogam is indicated in adults and children for replacement therapy in: primary immunodeficiency disease (pid) and symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

Intratect 100 g/l, solution for infusion (vial of 50 ml contains 5g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 50 ml contains 5g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 100 ml contains 10g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 100 ml contains 10g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 200 ml contains 20g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 200 ml contains 20g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins